Friday, July 16, 2010

Are medicinal plants still valued by pfizer, merck, & other research-based drug companies?

I am very interested in medicinal plants %26amp; herbs and their potential to cure cancer, AIDS, and other diseases. Can someone please give me insight into how valuable they are now to science and medicine and their future (value in the medicine business and science research) as well as with the FDA? Are they considered weak now and what about in the future? How can genetics and molecular biology be involved in research with these plants? What education do I need to be involved in the medicinal plant industry and in pfizer or other drug company giants?

Are medicinal plants still valued by pfizer, merck, %26amp; other research-based drug companies?
They sure are. Most of our pharmaceuticals were originally derived from plants before they were manufactured artificially. It is not so much a matter of being "weak" as it is a matter of being standardized in strength.





If you are interested, attend a good school of pharmacy and take all the pharmacology courses you can. You might want to do graduate work in pharmacology as well.


No comments:

Post a Comment